Displaying 1741 - 1770 of 2464
The challenge for this year is to overcome the pandemic and the immense sanitary and socio-economic inequality all over the world
Foundation is now the first institution in the country that is allowed to produce and distribute a 100% Brazilian COVID-19 vaccine
Image: Bernardo Portella/Bio-Manguinhos/Fiocruz
Protection against hospitalization and death exceeds 80% when compared to non-vaccinated infected people, shows study
The webinar brought together researchers from both sides who exchanged information on topics such as COVID-19, vaccines, zika and dengue
The research was conducted independently by researchers from different institutions, including Fiocruz and Oxford University
On the agenda, scientific cooperation, the XVI National Malaria Research Meeting and a symposium organized by the Foundation and the NIH
The new research, involving Brazil and Scotland´s data, was published at The Lancet
The TAG-VE consists of 25 scientists of excellence in different specialties, such as virology, bioinformatics, and epidemiology
The courses "What is Open Science?" and "Open Access" were translated from Portuguese into English and Spanish
Vigivac project analysed the four vaccines administered in Brazil, from January to October 2021, showing a great protection
Partnership between Fiocruz, the Ministry of Health, Lacen/PR and Unifesp includes training professionals and speeding up the response
Mortality is highest in ethnic minorities, poorer groups and the elderly. The economic effect is also unevenly distributed around the world
CB19-Fiocruz will enable the design and conduct of research, technological development and clinical trials
The campaign aims to stimulate leaders to invest more to make sure the world gets to 2030 closer to universal health coverage
The Foundation's exhibit at the Brazil Pavilion will open on December 28, with videos, games and lots of information to the visitors
Pietro Lazzeri met with Fiocruz members at the Fiocruz Global Health Center (CRIS/Fiocruz) and visited Bio-Manguinhos
O próximo passo será a assinatura do contrato para início das obras do futuro empreendimento, que será o maior centro de produção de produtos biológicos da América Latina e um dos mais modernos do mundo
Technical Seminar on Access to COVID-19 Vaccines brought together representatives of five countries days before bloc meeting
Otávio Pieri, of the Oswaldo Cruz Institute (IOC), was invited to become part of the group
Because of the COVID-19 pandemic, the conversation between the Foundation and Palace of Ife was stalled
Image: Bio-Manguinhos/Fiocruz
The request is to include Bio-manguinhos as the manufacturing unit of the Active Pharmaceutical Ingredient
Published in the 'Journal of Infectious Diseases', the study points out that process can lead to acute immunodeficiency in patients
Research highlights the second dose importance to guarantee more complete immunity and broader protection for the community
Fiocruz researcher Carlos Morel is member of Scientific Advisory Group for the Origins of Novel Pathogens (SAGO), formed by WHO
The Foundation joined the global campaign "Don't Forget Hansen's" and held a webinar about neglected diseases with Novartis
The initiative allows students to get dual-degrees or titles in master's and doctorate's degrees
Participants mention a lot of statements and commitments, but a lack of distinction of responsibilities and obligation in fulfilling the goals set
Nísia Trindade Lima was appointed for The World Academy of Sciences for the advancement of science in developing countries (TWAS)
Two webinars - from WHO and CRIS/Fiocruz- celebrated the document’s anniversary and evaluate the actions adopted since then